Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 136.11 g/mol |
---|---|
Molecular Formula | C5H4N4O |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 136.03851076 g/mol |
Monoisotopic Mass | 136.03851076 g/mol |
Topological Polar Surface Area | 65.8 A^2 |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 275 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 10 | |
---|---|
Drug Name | Allopurinol |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
2 of 10 | |
---|---|
Drug Name | Allopurinol sodium |
PubMed Health | Allopurinol (Injection) |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
3 of 10 | |
---|---|
Drug Name | Aloprim |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Mylan Institutional |
4 of 10 | |
---|---|
Drug Name | Lopurin |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Dr Reddys La |
5 of 10 | |
---|---|
Drug Name | Zyloprim |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Prometheus Labs |
6 of 10 | |
---|---|
Drug Name | Allopurinol |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
7 of 10 | |
---|---|
Drug Name | Allopurinol sodium |
PubMed Health | Allopurinol (Injection) |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
8 of 10 | |
---|---|
Drug Name | Aloprim |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Mylan Institutional |
9 of 10 | |
---|---|
Drug Name | Lopurin |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Dr Reddys La |
10 of 10 | |
---|---|
Drug Name | Zyloprim |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Prometheus Labs |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37104
Submission : 2023-01-20
Status : Active
Type : II
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39568
Submission : 2024-03-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4307
Submission : 1981-10-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4950
Submission : 1983-02-15
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5235
Submission : 1984-01-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3480
Submission : 1979-03-09
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2870
Submission : 1977-02-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2506
Submission : 1975-08-13
Status : Active
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3583
Submission : 1979-07-22
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2534
Submission : 1975-10-13
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
61
PharmaCompass offers a list of Allopurinol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Allopurinol manufacturer or Allopurinol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Allopurinol manufacturer or Allopurinol supplier.
PharmaCompass also assists you with knowing the Allopurinol API Price utilized in the formulation of products. Allopurinol API Price is not always fixed or binding as the Allopurinol Price is obtained through a variety of data sources. The Allopurinol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Allopurinol Pharmafarm Brand manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Allopurinol Pharmafarm Brand, including repackagers and relabelers. The FDA regulates Allopurinol Pharmafarm Brand manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Allopurinol Pharmafarm Brand API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Allopurinol Pharmafarm Brand manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Allopurinol Pharmafarm Brand supplier is an individual or a company that provides Allopurinol Pharmafarm Brand active pharmaceutical ingredient (API) or Allopurinol Pharmafarm Brand finished formulations upon request. The Allopurinol Pharmafarm Brand suppliers may include Allopurinol Pharmafarm Brand API manufacturers, exporters, distributors and traders.
click here to find a list of Allopurinol Pharmafarm Brand suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Allopurinol Pharmafarm Brand DMF (Drug Master File) is a document detailing the whole manufacturing process of Allopurinol Pharmafarm Brand active pharmaceutical ingredient (API) in detail. Different forms of Allopurinol Pharmafarm Brand DMFs exist exist since differing nations have different regulations, such as Allopurinol Pharmafarm Brand USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Allopurinol Pharmafarm Brand DMF submitted to regulatory agencies in the US is known as a USDMF. Allopurinol Pharmafarm Brand USDMF includes data on Allopurinol Pharmafarm Brand's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Allopurinol Pharmafarm Brand USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Allopurinol Pharmafarm Brand suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Allopurinol Pharmafarm Brand Drug Master File in Japan (Allopurinol Pharmafarm Brand JDMF) empowers Allopurinol Pharmafarm Brand API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Allopurinol Pharmafarm Brand JDMF during the approval evaluation for pharmaceutical products. At the time of Allopurinol Pharmafarm Brand JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Allopurinol Pharmafarm Brand suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Allopurinol Pharmafarm Brand Drug Master File in Korea (Allopurinol Pharmafarm Brand KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Allopurinol Pharmafarm Brand. The MFDS reviews the Allopurinol Pharmafarm Brand KDMF as part of the drug registration process and uses the information provided in the Allopurinol Pharmafarm Brand KDMF to evaluate the safety and efficacy of the drug.
After submitting a Allopurinol Pharmafarm Brand KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Allopurinol Pharmafarm Brand API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Allopurinol Pharmafarm Brand suppliers with KDMF on PharmaCompass.
A Allopurinol Pharmafarm Brand CEP of the European Pharmacopoeia monograph is often referred to as a Allopurinol Pharmafarm Brand Certificate of Suitability (COS). The purpose of a Allopurinol Pharmafarm Brand CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Allopurinol Pharmafarm Brand EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Allopurinol Pharmafarm Brand to their clients by showing that a Allopurinol Pharmafarm Brand CEP has been issued for it. The manufacturer submits a Allopurinol Pharmafarm Brand CEP (COS) as part of the market authorization procedure, and it takes on the role of a Allopurinol Pharmafarm Brand CEP holder for the record. Additionally, the data presented in the Allopurinol Pharmafarm Brand CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Allopurinol Pharmafarm Brand DMF.
A Allopurinol Pharmafarm Brand CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Allopurinol Pharmafarm Brand CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Allopurinol Pharmafarm Brand suppliers with CEP (COS) on PharmaCompass.
A Allopurinol Pharmafarm Brand written confirmation (Allopurinol Pharmafarm Brand WC) is an official document issued by a regulatory agency to a Allopurinol Pharmafarm Brand manufacturer, verifying that the manufacturing facility of a Allopurinol Pharmafarm Brand active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Allopurinol Pharmafarm Brand APIs or Allopurinol Pharmafarm Brand finished pharmaceutical products to another nation, regulatory agencies frequently require a Allopurinol Pharmafarm Brand WC (written confirmation) as part of the regulatory process.
click here to find a list of Allopurinol Pharmafarm Brand suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Allopurinol Pharmafarm Brand as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Allopurinol Pharmafarm Brand API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Allopurinol Pharmafarm Brand as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Allopurinol Pharmafarm Brand and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Allopurinol Pharmafarm Brand NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Allopurinol Pharmafarm Brand suppliers with NDC on PharmaCompass.
Allopurinol Pharmafarm Brand Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Allopurinol Pharmafarm Brand GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Allopurinol Pharmafarm Brand GMP manufacturer or Allopurinol Pharmafarm Brand GMP API supplier for your needs.
A Allopurinol Pharmafarm Brand CoA (Certificate of Analysis) is a formal document that attests to Allopurinol Pharmafarm Brand's compliance with Allopurinol Pharmafarm Brand specifications and serves as a tool for batch-level quality control.
Allopurinol Pharmafarm Brand CoA mostly includes findings from lab analyses of a specific batch. For each Allopurinol Pharmafarm Brand CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Allopurinol Pharmafarm Brand may be tested according to a variety of international standards, such as European Pharmacopoeia (Allopurinol Pharmafarm Brand EP), Allopurinol Pharmafarm Brand JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Allopurinol Pharmafarm Brand USP).